LRCX

Lam Research
D

LRCX

Arincen83/100B

Lam Research total debt 1986–2027

Lam Research's total debt was 3.74B USD on 27 September 2026, down 16.7% on a year before. At the end of fiscal year 2026 it was 4.12B USD.

Last updated 8 Nov 2026 · Next report 27 Jan 2027

Total debt

Growth

Fiscal yearPeriod endingTotal debtGrowthCash and short-term investmentsNet cashDebt to equity
Latest quarter27 Sept 20263.74B-16.69%7.44B3.70B0.27
FY202628 Jun 20264.12B-13.35%5.58B1.46B0.33
FY202529 Jun 20254.76B-4.55%6.39B1.63B0.48
FY202430 Jun 20244.98B-0.56%5.85B864.52M0.58
FY202325 Jun 20235.01B+0.11%5.37B363.16M0.61
FY202226 Jun 20225.01B+0.22%3.66B-1.35B0.80
FY202127 Jun 20215.00B-14.04%5.73B734.07M0.83
FY202028 Jun 20205.81B+29.42%6.71B899.53M1.12
FY201930 Jun 20194.49B+85.79%5.43B941.30M0.95
FY201830 Jun 20182.42B-10.28%4.95B2.53B0.37
FY201730 Jun 20172.69B-37.74%6.04B3.35B0.39
FY201630 Jun 20164.33B+83.22%6.83B2.50B0.71
FY201530 Jun 20152.36B+76.79%4.08B1.72B0.44
FY201430 Jun 20141.34B+2.42%3.07B1.73B0.26
FY201330 Jun 20131.30B+2.43%2.50B1.19B0.28
FY201230 Jun 20121.27B+71.26%2.86B1.59B0.24
FY201130 Jun 2011743.27M+3,187.06%2.12B1.38B0.30
FY201030 Jun 201022.61M-51.09%826.46M803.85M0.01
FY200930 Jun 200946.23M-84.91%579.39M533.15M0.03
FY200830 Jun 2008306.33M+22.53%1.06B752.41M0.17
FY200730 Jun 2007250.00M-28.57%670.69M420.69M0.21
FY200630 Jun 2006350.00M+12,462.81%1.05B700.34M0.25
FY200530 Jun 20052.79M-76.89%809.25M806.47M0.00
FY200430 Jun 200412.05M-96.43%429.47M417.42M0.01
FY200330 Jun 2003337.22M-50.04%507.41M170.19M0.52
FY200230 Jun 2002674.98M+0.94%874.21M199.22M1.00
FY200130 Jun 2001668.68M+103.07%864.56M195.88M0.94
FY200030 Jun 2000329.29M-5.12%371.72M42.43M0.52
FY199930 Jun 1999347.07M-1.27%311.80M-35.27M0.85
FY199830 Jun 1998351.54M+246.18%397.16M45.62M0.67
FY199730 Jun 1997101.55M+11.84%164.25M62.70M0.17
FY199630 Jun 199690.80M-12.27%130.48M39.68M0.15
FY199530 Jun 1995103.50M+20.91%101.01M-2.49M0.26
FY199430 Jun 199485.60M-0.93%24.10M-61.50M0.48
FY199330 Jun 199386.40M+336.36%67.30M-19.10M0.66
FY199230 Jun 199219.80M-26.12%25.80M6.00M0.19
FY199130 Jun 199126.80M+53.14%12.10M-14.70M0.44
FY199030 Jun 199017.50M+4.79%15.60M-1.90M0.32
FY198930 Jun 198916.70M+255.32%14.60M-2.10M0.29
FY198830 Jun 19884.70M+487.50%11.80M7.10M0.10
FY198730 Jun 1987800.00K-20.00%25.70M24.90M0.02
FY198630 Jun 19861.00M—23.40M22.40M0.02

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

Total debt counts commercial paper, term debt and lease liabilities.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Free cash flow,Stock buybacks,Balance sheet

Common questions about Lam Research's debt

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.